Moderna (MRNA) Stock Price, Quote, News & History | Benzinga

Moderna Inc (MRNA) Stock Price, Quote, News & History

MRNANASDAQ

Trade with Public

Trade with Public

$145.55

-3.32-2.23%

At close: Sep 4, 5:00 PM EST

$145.00

-0.55-0.38%

After Hours: 7:59 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$153.62

Close

$145.55

Volume / Avg.

14.97M / 15.33M

Day Range

$141.52 - $154.69

52 Wk Range

22.28 - 176.66

Market Cap

$57.51B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

63

Short Interest

16.29%

Days to Cover

9.15

Recent Moderna, Inc. News

This Sonoco Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

Analysts downgraded Ultragenyx, Moderna and Sonoco; targets fell for RARE and SON but rose for MRNA.

Avi Kapoor

CrowdStrike To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Thursday

Analysts revised price targets for Ultragenyx, UiPath, Netskope, Snowflake, Magnite, Broadcom, CrowdStrike and Moderna; ratings largely maintained.

Avi Kapoor

Moderna Stock Moves Lower Wednesday: What's Going On?

Shares of Moderna Inc (NASDAQ: MRNA) are trading lower Wednesday morning, taking a breather following a 170% surge over the trailing month.

Henry Khederian

Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today

The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate-hike odds to 68%, cracking high-multiple software stocks.

Piero Cingari

Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs

Moderna’s cancer vaccine breakthrough puts biotech, mRNA and genomics ETFs in focus. Here are the funds worth watching.

Chandrima Sanyal

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-1.07B

Investing Cash Flow (TTM)

905.00M

Financing Cash Flow (TTM)

611.00M

Free Cash Flow (TTM)

-1.24B

Capital Expenditure (TTM)

-171.00M

Net Change in Cash (TTM)

443.00M

Analyst Trends and Forecast

1

1

Jun

2

1

Jul

2

5

1

Aug

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

1.8

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$54.26B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

26.51

PB Ratio (TTM)

8.79

Earnings Yield % (TTM)

-5.36%

Earnings Yield % (FWD)

-2.65%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$16.93

Company Debt

Total Debt

$591.00M

LT Debt

$591.00M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$1.72B

Debt to Equity

0.19

Issuance of Debt (TTM)

$556.00M

Repayment of Debt (TTM)

-

Key Statistics

Open

$153.62

Close

$145.55

Volume / Avg.

14.97M / 15.33M

Day Range

$141.52 - $154.69

52 Wk Range

22.28 - 176.66

Market Cap

$57.51B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

63

Short Interest

16.29%

Days to Cover

9.15

About

Sector

Health Care

Industry

Biotechnology

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna h...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Moderna (MRNA) stock?

A

You can purchase shares of Moderna (NASDAQ:MRNA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Moderna (MRNA) competitors?

A

Other companies in Moderna’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Moderna (MRNA) stock?

A

Moderna has a consensus price target of $70.88.

Q

What is the current price for Moderna (MRNA)?

A

The stock price for Moderna (NASDAQ: MRNA) is $145 last updated September 4, 2026 at 7:59 PM EDT.

Q

Does Moderna (MRNA) pay a dividend?

A

There are no upcoming dividends for Moderna.

Q

When is Moderna (NASDAQ:MRNA) reporting earnings?

A

Moderna does not have any upcoming earnings scheduled.

Q

Is Moderna (MRNA) going to split?

A

There is no upcoming split for Moderna.

Q

What sector and industry does Moderna (MRNA) operate in?

A

Moderna is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Is Moderna's Stock Curing Cancer?

Is Moderna's Stock Curing Cancer?

Subscribe on YouTube

#TheDrift #TomSosnoff #Moderna

Aug 29, 2026

In this clip from The Drift, tastytrade founder Tom Sosnoff breaks down one of Wall Street's most enduring inside jokes and the moment it stopped being funny. Traders have used the phrase "what did they do, cure cancer?" for decades to describe any stock that makes an inexplicable, outsized move. Silver spikes. A semiconductor doubles overnight. A commodity goes parabolic. The phrase is universal shorthand: the move is so absurd it could only be explained by something truly miraculous. Sosnoff told Adam Mesh that he'd heard it and used it his entire career. And then Moderna happened. The company behind one of the most extreme stock moves in market history had actually done something comparably extraordinary. For once, the joke wasn't a joke. But Sosnoff's real observation is more unsettling: traders had been crying wolf with that phrase so many times, for so long, that when a stock finally earned it when the move was actually justified it almost didn't register. Watch the full episode of The Drift on Benzinga's YouTube channel. $MRNA. #TheDrift #TomSosnoff #Moderna 🌐 Find more market-moving insights at https://www.benzinga.com — your one-stop destination for the latest financial news, data, and expert analysis to stay ahead of the markets. 🖥️ Want the same tools the pros use—without the $10K Bloomberg terminal? Benzinga Edge gives you real-time portfolio alerts, weekly stock picks, and pro-grade research in one command center. 👉 https://bit.ly/4unSKiB ------------------------------------------------------------------------------------ 📲 Follow us on socials @benzinga 🔔 Subscribe To The Channel: https://www.youtube.com/@Benzinga ------------------------------------------------------------------------------------ ⚠️ Disclaimer: Investing in financial markets carries risk, and there are no guaranteed returns. All information is for educational purposes only and should not be taken as financial advice. Always do your own research and speak with a qualified financial advisor before making investment decisions. Only invest what you can afford to lose. Past performance does not guarantee future outcomes.

More MRNA videos